APA (7th ed.) Citation

M, W., & Z, D. (2020). CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter]. Dove Medical Press.

Chicago Style (17th ed.) Citation

M, Wei, and Duan Z. CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter]. Dove Medical Press, 2020.

MLA (8th ed.) Citation

M, Wei, and Duan Z. CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter]. Dove Medical Press, 2020.